StocksTelegraph
S&P 500—NASDAQ—DOW—RUSSELL—
NYSE · STE·Healthcare

STERIS plc Stock Analysis & AI Score

STERIS plc (STE) has an ST Score of 55.7 (B-), driven by its Profitability (A) and held back by its Valuation (D-). Analysts rate it Buy with a $271.33 price target (+30.0% upside).

Market Closed
$208.77
Prev Close
—
Market Cap
—
Day Range
—
52W Range
—
P/E
—
EPS (TTM)
—
Volume
—
Avg —
Beta
—
56
ST Score
55.7/100B-

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
—
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees—
CEO—
SectorHealthcare
IndustryMedical - Specialties
IPO Date—
Website—
Country—
ExchangeNYSE

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

STE
55.7out of 100
Grade B-

STERIS plc (STE) has an ST Score of 55.7 (B-), driven by its Profitability (A) and held back by its Valuation (D-). Analysts rate it Buy with a $271.33 price target (+30.0% upside).

Strongest
ProfitabilityA
Weakest
ValuationD-
All factor grades
  • ProfitabilityA
  • MomentumB+
  • ForecastB-
  • GrowthC+
  • Financial StrengthC-
  • ValuationD-
  • Piotroski8/9
Score methodology
Press Releases

Contact

STE stock: frequently asked questions

What is STE's ST Score?

STERIS plc (STE) has an ST Score of 55.7 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is STE a buy, hold, or sell?

Analysts rate STE a Buy, with a price target of $271.33 (+30.0% vs the current price). Our ST Score grades it B- (55.7/100). The ST Score is a data-driven signal, not a recommendation.

What are STE's factor grades?

Valuation D-, Profitability A, Financial Strength C-, Momentum B+, Growth C+, Forecast B-.

What is STE's valuation grade?

STERIS plc (STE) earns a valuation grade of D-, measured against Medical - Specialties peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is STE's growth grade?

STERIS plc (STE) earns a growth grade of C+, measured against Medical - Specialties peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is STE's profitability grade?

STERIS plc (STE) earns a profitability grade of A, measured against Medical - Specialties peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is STE's financial strength grade?

STERIS plc (STE) earns a financial strength grade of C-, measured against Medical - Specialties peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is the analyst price target for STE?

The average analyst price target for STERIS plc (STE) is $271.33 from 14 analysts, which is +30.0% versus the recent price of $208.77.

What is STE's Piotroski score?

STERIS plc (STE) has a Piotroski F-Score of 8 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.